RNAseq  and TCRseq analysis of entinostat treated bladder tumors
We present transcriptome profiling, TCR repertoire and WES of mouse bladder tumors with and without entinostat treatment, which is a HDAC inhibitor Overall design: BBN963 cells were injected subcutaneously in C57BL/6 mice at 3.0 x 10^6 cells. Once tumors reached 200mm3 in tumor volume, mice were randomized and treated with chow containing entinostat (12mg/kg). Entinostat treated tumors were collected at 100mm3